Keywords: dynavax, gets, 5m, milestone, az, firm, technologies
Dynavax gets $4.5M milestone from AZ
Article | 29 September 2008
US firm Dynavax Technologies has received a $4.5-million milestone payment from its partner, Anglo-Swedish drug major AstraZeneca, for the nomination ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
